ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 18 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Why TruGolf Holdings Inc. (NASDAQ: TRUG) Is ‘One to Watch’
TruGolf (NASDAQ: TRUG) is pursuing a strategic expansion into blockchain-based financial infrastructure through its pending…
-
QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Brings Interactive Experiences to Major Sports and Entertainment Audiences
Versus Systems (NASDAQ: VS) uses gamification and audience engagement technology to help brands, sports teams,…
-
QualityStocksNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Builds Momentum with Potential 1,500-Home Pipeline
BOXABL (NASDAQ: BXBL) has signed a multiyear purchase agreement with LC Vegas Acquisitions, LLC for…